CAJ | 학술논문

目的：探讨左卡尼汀补充LC治疗对糖尿病肾病患者脂代谢和LC群的影响。方法：78例糖尿病肾病患者随机数字表法分为两组，对照组采用常规治疗，实验组在常规治疗基础上增加左卡尼汀口服溶液治疗，比较各组治疗前后血糖、血脂和卡尼汀群变化。结果：治疗后实验组与对照组FPG、TG、TC、HDL和LDL相比，差异具有统计学意义（P<0.05）；实验组LC与对照组相比，差异具有统计学意义（P<0.05）。结论：左卡尼汀能够纠正糖尿病肾病患者的能量代谢紊乱，有利于血糖的控制。
목적：탐토좌잡니정보충LC치료대당뇨병신병환자지대사화LC군적영향。방법：78례당뇨병신병환자수궤수자표법분위량조，대조조채용상규치료，실험조재상규치료기출상증가좌잡니정구복용액치료，비교각조치료전후혈당、혈지화잡니정군변화。결과：치료후실험조여대조조FPG、TG、TC、HDL화LDL상비，차이구유통계학의의（P<0.05）；실험조LC여대조조상비，차이구유통계학의의（P<0.05）。결론：좌잡니정능구규정당뇨병신병환자적능량대사문란，유리우혈당적공제。
Objective:To investigate L-carnitine supplementation of LC therapy on lipid metabolism and the effect of diabetes LC group.Method:78 patients were randomly divided into 2 groups,control group accepted conventional therapy,experimental group increased Levocarnitine Oral Solution treatment on the basis of conventional treatment, blood glucose,blood lipid before and after treatment and the changes of carnitine between the two groups was compared. Result:After treatment,the experimental group and the control group FPG,TG,TC,HDL and LDL was compared and the difference was statistically significant(P<0.05).LC in the experimental group compared with the control group,the difference was statistically significant(P<0.05).Conclusion:L-carnitine can correct the disorder of energy metabolism in patients with diabetic nephropathy,improve the control of blood glucose.